| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/27/1995 | EP0673420A1 Mammalian receptors for interleukin-10 (il-10) |
| 09/27/1995 | EP0673419A1 Stably transfected cell lines expressing gaba-a receptors |
| 09/27/1995 | EP0673418A1 Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications |
| 09/27/1995 | EP0673414A1 Method for enhancing the differentiation of plant cells in culture |
| 09/27/1995 | EP0673392A1 Method of preferential labelling of phycobiliprotein with amine-reactive dye for use in a multiple color assay |
| 09/27/1995 | EP0673391A1 Activation-dependent protein expressed on the surface of activated platelets and antibodies thereto |
| 09/27/1995 | EP0673390A1 Delta-like gene expressed in neuroendocrine tumors |
| 09/27/1995 | EP0673388A1 Double chain peptide compounds having hemoregulatory activity |
| 09/27/1995 | EP0673386A1 Methods and compositions for detecting anti-hepatitis e virus activity |
| 09/27/1995 | EP0673385A1 Mammalian gap-43 compositions and methods of use |
| 09/27/1995 | EP0673384A1 Polypeptides useful for treating inflammatory disorders |
| 09/27/1995 | EP0673383A1 Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same |
| 09/27/1995 | EP0673257A1 Low toxicity interleukin-2 analogues for use in immunotherapy |
| 09/27/1995 | EP0673256A1 Suppression of myeloid cells |
| 09/27/1995 | EP0673255A1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 09/27/1995 | EP0593460B1 Method and apparatus for biopolymer synthesis |
| 09/27/1995 | EP0573554B1 Use of at least one purified peptide obtainable by hydrolysis of casein and having opioid activity as active principle in the manufacture of a cosmetic composition |
| 09/27/1995 | EP0348490B1 Treatment of type 2 diabetes mellitus |
| 09/27/1995 | EP0261225B1 Lectin complex and method and probe for making same |
| 09/26/1995 | US5453492 60 kDa transforming growth factor-β-binding protein and its use to detect or purify TGF-β |
| 09/26/1995 | US5453491 Purified and comprising specified amino acid sequences; therapy for autoimmune disorders and eosinophilia |
| 09/26/1995 | US5453490 Production of recombinant human interleukin-1 inhibitor |
| 09/26/1995 | US5453489 Specific amino acid sequences; bind directly to fibronectin, reduces matrix assembly without affecting binding to cells; antitumor/wound healing agents |
| 09/26/1995 | US5453488 Amino-substituted heterocycles as renin inhibitors |
| 09/26/1995 | US5453419 Xenopus laevis bone morphogenetic proteins and use thereof |
| 09/26/1995 | US5453417 Process for the phosphorylation of insulin and product produced thereby |
| 09/26/1995 | US5453373 Protein C derivatives |
| 09/26/1995 | US5453370 Method for the preparation of a phospholipid-dependent prothrombin activator from the venom of snakes |
| 09/26/1995 | US5453364 Recombinant poxvirus host range selection system |
| 09/26/1995 | US5453363 Solubilizing, reducing, and denaturing refractile bodies; oxidation with glutathione; genetic engineering |
| 09/26/1995 | US5453362 Herpes virus, viricides |
| 09/26/1995 | US5453361 Method for producing biologically active human brain derived neurotrophic factor |
| 09/26/1995 | US5453359 Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers |
| 09/26/1995 | US5453354 Method for improving sperm motility |
| 09/26/1995 | US5453272 Serine-proline-tyrosine-glycine-arginine-cysteine hexapeptide; immunosuppressant |
| 09/26/1995 | US5453270 Pharmaceutical composition and method for hypermetabolic weight loss |
| 09/26/1995 | CA2145623A1 Modulatory proteins of human cns receptors |
| 09/26/1995 | CA1337120C Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccines containing same |
| 09/26/1995 | CA1337115C Vaccination against rabies-related diseases |
| 09/22/1995 | CA2144936A1 Antibody conjugates with improved properties |
| 09/21/1995 | WO1995025273A1 Methods and devices for automatic assessment of corn |
| 09/21/1995 | WO1995025173A1 Methods for identifying inhibitors of integrin activation |
| 09/21/1995 | WO1995025170A1 NOVEL MUTEINS OF IFN-$g(b) |
| 09/21/1995 | WO1995025169A1 CHIMERIC GENE USING THE GENE OR cDNA OF INSULINE, SPECIALLY FOR THE GENE THERAPY OF DIABETES |
| 09/21/1995 | WO1995025168A1 Use of a recombinant inhibitor from erythrina caffra for purifying serine proteases |
| 09/21/1995 | WO1995025166A1 Methods for treatment or diagnosis of diseases or conditions associated with abnormal signal transduction |
| 09/21/1995 | WO1995025165A1 cDNAs ENCODING MINOR AMPULLATE SPIDER SILK PROTEINS |
| 09/21/1995 | WO1995025125A1 Dna encoding cai resistance proteins and uses thereof |
| 09/21/1995 | WO1995025124A1 Methods to diagnose and treat hiv-1 infection |
| 09/21/1995 | WO1995025123A1 Peptides inhibiting the release of pepsine |
| 09/21/1995 | WO1995025122A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus |
| 09/21/1995 | WO1995025121A1 Enhancement of antitumor therapy with hemoglobin-based conjugates |
| 09/21/1995 | WO1995025120A1 Peptide vaccines and methods relating thereto |
| 09/21/1995 | WO1995025117A1 Polypeptides of lipopolysaccharide binding protein |
| 09/21/1995 | WO1995025114A1 Plant peptide transport gene |
| 09/21/1995 | WO1995024928A2 Heparin-binding growth factors for gene therapy and anterior eye disorders |
| 09/21/1995 | WO1995024926A1 Formulation for use in inducing cytotoxic t-cells |
| 09/21/1995 | WO1995024925A1 Cytotoxic t-cell epitopes |
| 09/21/1995 | WO1995024923A2 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
| 09/21/1995 | WO1995024920A1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor |
| 09/21/1995 | WO1995024918A1 Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases |
| 09/21/1995 | WO1995024916A1 Retropeptides, antibodies thereto, and uses thereof for vaccination and in vitro diagnosis |
| 09/21/1995 | WO1995024915A1 Product and process for regulating signal transduction pathways |
| 09/21/1995 | WO1995024913A1 Treatment of graft-versus-host disease |
| 09/21/1995 | WO1995021858A3 Mosaic polypeptide and methods for detecting the hepatitis e virus |
| 09/21/1995 | WO1995021601A3 Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof |
| 09/21/1995 | WO1995018826A3 Purified primate ctla-8 antigens and related reagents |
| 09/21/1995 | DE4424171A1 Verwendung von rekombinantem Inhibitor aus Erythrina caffra zur Reinigung von Serinproteasen Use of recombinant inhibitor from Erythrina caffra for the purification of serine proteases |
| 09/21/1995 | CA2207851A1 Plant peptide transport gene |
| 09/21/1995 | CA2187781A1 Methods for treatment or diagnosis of diseases or conditions associated with abnormal signal transduction |
| 09/21/1995 | CA2185671A1 Heparin-binding growth factors for gene therapy and anterior eye disorders |
| 09/21/1995 | CA2185651A1 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
| 09/21/1995 | CA2185540A1 Formulation for use in inducing cytotoxic t-cells |
| 09/21/1995 | CA2185539A1 Blood-borne mesenchymal cells |
| 09/21/1995 | CA2185534A1 Peptide vaccines and methods relating thereto |
| 09/21/1995 | CA2185446A1 Methods for identifying inhibitors of integrin activation |
| 09/21/1995 | CA2185433A1 Enhancement of antitumor therapy with hemoglobin-based conjugates |
| 09/21/1995 | CA2185341A1 Dna encoding cai resistance proteins and uses thereof |
| 09/21/1995 | CA2185324A1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor |
| 09/21/1995 | CA2185129A1 Methods to diagnose and treat hiv-1 infection |
| 09/21/1995 | CA2184631A1 Product and process for regulating signal transduction pathways |
| 09/20/1995 | EP0672757A1 Functional assay method for the identification of thrombin receptor antagonists |
| 09/20/1995 | EP0672754A1 Plant virus vector, plasmid, method of expressing foreign gene, and method of acquiring foreign gene product |
| 09/20/1995 | EP0672753A1 Multicloning vector, expression vector, and production of foreign protein with expression vector |
| 09/20/1995 | EP0672701A1 PNA-synthesis using a base labile aminoprotecting group |
| 09/20/1995 | EP0672700A1 PNA-synthesis using an aminoprotecting group which is labile against weak acids |
| 09/20/1995 | EP0672685A2 Monoclonal antibody |
| 09/20/1995 | EP0672684A1 Novel megakaryocyte colony stimulating factor and production thereof |
| 09/20/1995 | EP0672683A1 Macif protein, genes coding therefor, expression vectors containing said genes, and transformant cells containing said protein |
| 09/20/1995 | EP0672682A1 hPTH(1-36) peptides, their preparation and pharmaceutical compositions |
| 09/20/1995 | EP0672681A1 Novel antitumor peptide |
| 09/20/1995 | EP0672680A1 Novel peptide |
| 09/20/1995 | EP0672677A2 Polyamide-oligonucleotide derivatives, their production and use |
| 09/20/1995 | EP0672421A1 Endothelin activity inhibitor |
| 09/20/1995 | EP0672253A1 Carcinoma associated antigen (sk1) monoclonal antibodies against sk1, methods of producing these antibodies and use therfor |
| 09/20/1995 | EP0672192A1 Method for inhibition of viral morphogenesis |
| 09/20/1995 | EP0672160A1 Activating expression of an amplifying endogenous gene by homologous recombination |
| 09/20/1995 | EP0672159A1 In vivo homologous sequence targeting in eukaryotic cells |
| 09/20/1995 | EP0672158A1 Virus with modified binding moiety specific for the target cells |
| 09/20/1995 | EP0672157A1 Recombinant viruses comprising artificial proteolytic cleavage site |